To help residents with the high cost of insulin, a necessary drug for patients with diabetes, the state of California decided to develop its own generic brand of the medicine. The project will begin distributing “CalRx” insulin to consumers in January, and the San Jose Mercury News spoke to Professor Jacob Sherkow about how this plan is affecting insulin more broadly. The plan, he explained, is putting “downward pressure” on prices across the market.
